A comparative trial of tiotropium, salmeterol and placebo: health-related quality of life Source: Eur Respir J 2001; 18: Suppl. 33, 26s Year: 2001
Indacaterol once-daily improves health-related quality of life (HRQOL) in COPD patients: a 52-week study Source: Annual Congress 2009 - New bronchodilators Year: 2009
A prospective observational study of the impact of COPD on daily life following the initiation of indacaterol Source: International Congress 2014 – Clinical assessment of airway diseases Year: 2014
Indacaterol once-daily improves health-related quality of life in COPD patients: a 26-week comparison with placebo and tiotropium Source: Annual Congress 2009 - New bronchodilators Year: 2009
Patients with COPD using salmeterol/fluticasone propionate combination therapy experience improved quality of life Source: Eur Respir J 2003; 22: Suppl. 45, 51s Year: 2003
A multicenter, open-label, randomized comparison of the effects of HFA-BDP and FP on asthmatic inflammation of lower airways and health-related quality of life Source: Eur Respir J 2007; 30: Suppl. 51, 616s Year: 2007
Health-related quality of life and asthma control in patients treated with budesonide and formoterol in a single inhaler Source: Eur Respir J 2001; 18: Suppl. 33, 46s Year: 2001
Fluticasone propionate/formoterol therapy for asthmatic patients: Results of a non-interventional study Source: International Congress 2016 – Asthma management Year: 2016
Asthma control in asthmatics treated with extrafine or non-extrafine ICS/LABA combinations in real life setting Source: Annual Congress 2013 –Diagnosis and management of respiratory diseases Year: 2013
Tiotropium + olodaterol fixed-dose combination shows clinically meaningful improvements in quality of life versus placebo Source: International Congress 2015 – New data on established treatments for asthma, COPD and bronchiectasis Year: 2015
Switch from LABA+ICS to a LABA/LAMA combination in symptomatic women with COPD – an analysis of the observational DACCORD study Source: International Congress 2018 – Pharmacological management of COPD Year: 2018
Quality of life in children with asthma in Russia: results of multi-center population study Source: Eur Respir J 2004; 24: Suppl. 48, 382s Year: 2004
Single inhaler triple therapy in patients with COPD: response rates in health-related quality of life in the IMPACT Trial Source: International Congress 2018 – Clinical trials in COPD: new results Year: 2018
NVA237 once daily improves dyspnea and health-related quality of life (HRQoL) in patients with COPD: The GLOW1 trial Source: Annual Congress 2011 - Bronchodilators in asthma and COPD Year: 2011
Effect of a self-management programme on health-related quality of life in COPD patients: a randomised controlled trial Source: Eur Respir J 2002; 20: Suppl. 38, 377s Year: 2002
The effect of COPD and FEV1 decline on health-related quality of life: A longitudinal, population-based study Source: Annual Congress 2013 –Risk factors for COPD and lung function decline Year: 2013
Health status changes in COPD patients after real-life switch from tiotropium or salmeterol/fluticasone to indacaterol/glycopyrronium using the EQ-5D-3L instrument: results from the POWER study Source: International Congress 2018 – COPD management Year: 2018
A placebo controlled trial with inhaled mannitol improves health related quality of life in patients with bronchiectasis Source: Annual Congress 2004 - Bronchiectasis Year: 2004
Safety of formoterol in children and adolescents: experience from asthma clinical trials Source: Annual Congress 2008 - Drug therapy and assessment of control in childhood asthma Year: 2008
The experience of study of comparative efficiency of seretid, fluticasone and beclametasone at children Source: Eur Respir J 2004; 24: Suppl. 48, 165s Year: 2004